EGFR and uveal melanoma: Of the 4 samples that had an IndexSUM of <300 and the 6 samples that demonstrated >50% inhibition at 100% TDC when tested with single agent gefitinib, 2 samples (a uveal melanoma and an unknown primary) had material available for immunohistochemical staining with EGFR and pAkt.